LIGAND PHARMACEUTICALS INCORPORATED Disposal Group, Including Discontinued Operation, Deferred Revenue, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Disposal Group, Including Discontinued Operation, Deferred Revenue, Current of $2.46 million as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Disposal Group, Including Discontinued Operation, Liabilities, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent · last filed 2020-11-06
- 2020-09-30: Disposal Group, Including Discontinued Operation, Deferred Revenue, Current $2.46M.
| Period end | Disposal Group, Including Discontinued Operation, Deferred Revenue, Current |
|---|---|
| 2020-09-30 | $2.46M 10-Q · filed 2020-11-06 |